Lund, Sweden, 16.30 CET, 19 November 2020 – BONESUPPORT HOLDING AB (publ), an emerging leader in orthobiologics for the management of bone injuries, today announces that Simon Cartmell has asked to leave the Board of Directors with immediate effect, to focus on other engagements.
“I would like to thank Simon Cartmell for valuable contributions to the company’s development since 2018 and wish him the best of luck with his new engagements,” said Lennart Johansson, Chairman of the Board of BONESUPPORT.
For more information, please contact:
+46 (0) 708 76 87 87
BONESUPPORT (Nasdaq Stockholm: BONEX) develops and commercializes innovative injectable bio-ceramic bone graft substitutes that remodel to the patient’s own bone and have the capability of eluting drugs. BONESUPPORT’s bone graft substitutes are based on the patented technology platform CERAMENT. The company is conducting several clinical studies to further demonstrate the clinical and health economic benefits that its products deliver. The company is based in Lund, Sweden, and the net sales amounted to SEK 155 million in 2019. Please visit www.bonesupport.com for more information.
BONESUPPORT and CERAMENT are registered trademarks of BONESUPPORT AB.